Annual Current Liabilities
$254.25 M
+$128.62 M+102.38%
31 December 2023
Summary:
ACADIA Pharmaceuticals annual total current liabilities is currently $254.25 million, with the most recent change of +$128.62 million (+102.38%) on 31 December 2023. During the last 3 years, it has risen by +$158.19 million (+164.66%). ACAD annual current liabilities is now at all-time high.ACAD Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$343.94 M
+$6.09 M+1.80%
30 September 2024
Summary:
ACADIA Pharmaceuticals quarterly total current liabilities is currently $343.94 million, with the most recent change of +$6.09 million (+1.80%) on 30 September 2024. Over the past year, it has increased by +$89.69 million (+35.28%). ACAD quarterly current liabilities is now at all-time high.ACAD Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACAD Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +35.3% |
| 3 y3 years | +164.7% | +258.0% |
| 5 y5 years | +239.8% | +359.7% |
ACAD Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +164.7% | at high | +258.0% |
| 5 y | 5 years | at high | +239.8% | at high | +359.7% |
| alltime | all time | at high | +4174.6% | at high | +5939.4% |
ACADIA Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $343.94 M(+1.8%) |
| June 2024 | - | $337.85 M(+2.2%) |
| Mar 2024 | - | $330.60 M(+30.0%) |
| Dec 2023 | $254.25 M(+102.4%) | $254.25 M(+21.3%) |
| Sept 2023 | - | $209.60 M(+11.5%) |
| June 2023 | - | $187.94 M(-16.2%) |
| Mar 2023 | - | $224.30 M(+78.5%) |
| Dec 2022 | $125.63 M(+30.8%) | $125.63 M(+7.8%) |
| Sept 2022 | - | $116.57 M(-0.9%) |
| June 2022 | - | $117.68 M(-1.6%) |
| Mar 2022 | - | $119.60 M(+24.5%) |
| Dec 2021 | $96.07 M(-9.3%) | $96.07 M(+8.9%) |
| Sept 2021 | - | $88.22 M(-7.5%) |
| June 2021 | - | $95.33 M(-12.8%) |
| Mar 2021 | - | $109.37 M(+3.2%) |
| Dec 2020 | $105.97 M(+41.6%) | $105.97 M(+15.4%) |
| Sept 2020 | - | $91.86 M(+6.3%) |
| June 2020 | - | $86.42 M(-13.4%) |
| Mar 2020 | - | $99.74 M(+33.3%) |
| Dec 2019 | $74.83 M(+25.6%) | $74.83 M(+10.5%) |
| Sept 2019 | - | $67.74 M(+6.2%) |
| June 2019 | - | $63.81 M(-14.9%) |
| Mar 2019 | - | $74.98 M(+25.9%) |
| Dec 2018 | $59.56 M(+21.5%) | $59.56 M(+42.5%) |
| Sept 2018 | - | $41.81 M(-15.1%) |
| June 2018 | - | $49.21 M(+6.8%) |
| Mar 2018 | - | $46.09 M(-6.0%) |
| Dec 2017 | $49.03 M(+15.1%) | $49.03 M(+35.7%) |
| Sept 2017 | - | $36.14 M(-11.7%) |
| June 2017 | - | $40.91 M(-9.6%) |
| Mar 2017 | - | $45.27 M(+6.3%) |
| Dec 2016 | $42.59 M(+94.4%) | $42.59 M(+8.8%) |
| Sept 2016 | - | $39.15 M(+34.9%) |
| June 2016 | - | $29.02 M(+37.4%) |
| Mar 2016 | - | $21.12 M(-3.6%) |
| Dec 2015 | $21.90 M(+38.3%) | $21.90 M(+23.5%) |
| Sept 2015 | - | $17.73 M(-8.5%) |
| June 2015 | - | $19.38 M(+16.4%) |
| Mar 2015 | - | $16.65 M(+5.2%) |
| Dec 2014 | $15.83 M | $15.83 M(+40.7%) |
| Sept 2014 | - | $11.25 M(+20.5%) |
| June 2014 | - | $9.34 M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $8.03 M(+15.1%) |
| Dec 2013 | $6.98 M(+17.3%) | $6.98 M(-11.3%) |
| Sept 2013 | - | $7.87 M(+1.2%) |
| June 2013 | - | $7.78 M(+36.5%) |
| Mar 2013 | - | $5.70 M(-4.3%) |
| Dec 2012 | $5.95 M(-3.5%) | $5.95 M(-2.3%) |
| Sept 2012 | - | $6.09 M(-10.0%) |
| June 2012 | - | $6.76 M(+5.1%) |
| Mar 2012 | - | $6.43 M(+4.3%) |
| Dec 2011 | $6.17 M(+3.5%) | $6.17 M(-3.8%) |
| Sept 2011 | - | $6.41 M(+7.8%) |
| June 2011 | - | $5.95 M(-3.1%) |
| Mar 2011 | - | $6.14 M(+3.0%) |
| Dec 2010 | $5.96 M(-59.5%) | $5.96 M(-54.7%) |
| Sept 2010 | - | $13.17 M(+1.4%) |
| June 2010 | - | $12.98 M(-4.2%) |
| Mar 2010 | - | $13.55 M(-7.9%) |
| Dec 2009 | $14.71 M(+33.1%) | $14.71 M(-3.5%) |
| Sept 2009 | - | $15.25 M(-27.2%) |
| June 2009 | - | $20.94 M(+83.1%) |
| Mar 2009 | - | $11.44 M(+3.5%) |
| Dec 2008 | $11.05 M(-42.7%) | $11.05 M(-1.3%) |
| Sept 2008 | - | $11.20 M(-19.3%) |
| June 2008 | - | $13.89 M(+3.1%) |
| Mar 2008 | - | $13.47 M(-30.1%) |
| Dec 2007 | $19.29 M(-6.1%) | $19.29 M(+12.4%) |
| Sept 2007 | - | $17.16 M(+19.7%) |
| June 2007 | - | $14.33 M(-17.1%) |
| Mar 2007 | - | $17.27 M(-15.9%) |
| Dec 2006 | $20.53 M(-5.4%) | $20.53 M(-1.1%) |
| Sept 2006 | - | $20.77 M(-17.9%) |
| June 2006 | - | $25.31 M(+16.4%) |
| Mar 2006 | - | $21.74 M(+0.2%) |
| Dec 2005 | $21.70 M(+151.1%) | $21.70 M(+10.2%) |
| Sept 2005 | - | $19.69 M(+77.7%) |
| June 2005 | - | $11.08 M(-5.3%) |
| Mar 2005 | - | $11.69 M(+35.3%) |
| Dec 2004 | $8.64 M(+5.0%) | $8.64 M(-7.7%) |
| Sept 2004 | - | $9.36 M(-2.1%) |
| June 2004 | - | $9.57 M(-8.4%) |
| Mar 2004 | - | $10.44 M(+26.9%) |
| Dec 2003 | $8.23 M(+33.7%) | $8.23 M |
| Dec 2002 | $6.15 M | - |
FAQ
- What is ACADIA Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly current liabilities year-on-year change?
What is ACADIA Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ACAD is $254.25 M
What is the all time high annual current liabilities for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual total current liabilities is $254.25 M
What is ACADIA Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ACAD is $343.94 M
What is the all time high quarterly current liabilities for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly total current liabilities is $343.94 M
What is ACADIA Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ACAD quarterly total current liabilities has changed by +$89.69 M (+35.28%)